企業プロフィール
GeneDx 株価・ニュース・カタリスト
- ティッカー:
- WGS
- 取引所:
- NASDAQ
- セクター:
- Biopharma
- 所在地:
- United States
株価パフォーマンス
87.06 USD (+5.47%)
終値
最終更新: 2026年8月21日
1.58B USD
時価総額
株価変動の要因
As of Aug 21, 2026, WGS closed up 5.47% at $87.06. No new same-company headline was identified in the current news window.
企業概要
事業概要
GeneDx is a genomics diagnostics company focused on rare-disease testing, exome sequencing, and clinical genetics. Its business helps clinicians diagnose difficult genetic conditions more efficiently.
所在地とセクター分類
Headquartered in the United States and listed on NASDAQ, GeneDx sits in molecular diagnostics and genomics.
ビジネスモデルの特徴
The company depends on test adoption, reimbursement, and the expansion of genomic testing across clinical settings.
バイオ業界での位置付け
GeneDx is a diagnostics platform name whose stock is driven by adoption, reimbursement, and workflow scale.
今後のカタリスト
- GeneDx’s catalysts are exome and genome testing volumes, reimbursement, and whether the rare-disease diagnostics franchise keeps expanding. The next update matters because the company’s value is still tied to workflow adoption and test mix.
最近のニュース
- 01
- 02
- 03
- 04
- 05
類似銘柄
事業成熟度、治療領域、カタリスト傾向が近い同業銘柄です。